In this study we show that while the BRAF-i PLX4032 had no significant effect, the MEK-i PD0325901 strongly inhibited the surface expression of the main activating receptors and the anti-tumor activity of freshly isolated NK cells cultured with IL-2 or IL-15. Here, IL2 is linked to neoplasm.